Trial Profile
Drug Utilization Study for Olodaterol
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Jul 2022
Price :
$35
*
At a glance
- Drugs Olodaterol (Primary) ; Indacaterol
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 09 Apr 2018 Status changed from active, no longer recruiting to completed.
- 02 Nov 2017 Status changed from recruiting to active, no longer recruiting.
- 01 Mar 2017 Status changed from not yet recruiting to recruiting.